Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China · Delayed Price · Currency is CNY 48.43
-1.75 (-3.49%)
May 14, 2026, 3:04 PM CST
SHE:300832 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,625 | 1,620 | 1,828 | 1,654 | 1,328 | 973.7 |
Depreciation & Amortization | 196.4 | 196.4 | 185.61 | 154.33 | 116.48 | 97 |
Other Amortization | 38.21 | 38.21 | 33.45 | 24.87 | 15.68 | 13.4 |
Loss (Gain) From Sale of Assets | - | - | -0.02 | -0.05 | -0.62 | -0.1 |
Asset Writedown & Restructuring Costs | 1.64 | 1.64 | 0.41 | 1.52 | 1.52 | 1.86 |
Loss (Gain) From Sale of Investments | -77.14 | -77.14 | -118.47 | -92.94 | -76.95 | -71.67 |
Provision & Write-off of Bad Debts | 20.04 | 20.04 | 28.01 | 10.78 | 14.32 | -7.37 |
Other Operating Activities | 380.91 | 44.97 | 89.84 | -9.03 | -50.41 | 26.55 |
Change in Accounts Receivable | -226.16 | -226.16 | -612.94 | -277.18 | -240.16 | -154.66 |
Change in Inventory | 110.78 | 110.78 | -382.5 | -136.49 | -229.95 | -227.73 |
Change in Accounts Payable | -211.37 | -211.37 | 304.21 | 84.02 | 162.12 | 10.03 |
Change in Other Net Operating Assets | - | - | - | - | -80.71 | 93.88 |
Operating Cash Flow | 1,863 | 1,522 | 1,356 | 1,418 | 962.39 | 773.22 |
Operating Cash Flow Growth | 67.33% | 12.23% | -4.36% | 47.37% | 24.47% | -20.83% |
Capital Expenditures | -342.84 | -311.44 | -439.2 | -322.2 | -403.22 | -342.94 |
Sale of Property, Plant & Equipment | 0.05 | 0.04 | 0.11 | 0.09 | 0.66 | 0.24 |
Sale (Purchase) of Intangibles | - | - | - | - | -16.62 | - |
Investment in Securities | 442.97 | -132.79 | -361.86 | -53.47 | -261.5 | -634.54 |
Other Investing Activities | 44.77 | 30.79 | 95.8 | 84.85 | 86.96 | 52.67 |
Investing Cash Flow | 144.95 | -413.4 | -705.15 | -290.73 | -593.72 | -924.57 |
Long-Term Debt Repaid | - | -4.61 | -4.24 | -4.11 | -4.05 | -3.59 |
Net Debt Issued (Repaid) | -4.61 | -4.61 | -4.24 | -4.11 | -4.05 | -3.59 |
Issuance of Common Stock | - | - | - | - | - | 129.56 |
Repurchase of Common Stock | - | - | - | -16.29 | -21.62 | - |
Common Dividends Paid | -1,022 | -1,022 | -785.96 | -548.21 | -471.78 | -413.4 |
Other Financing Activities | -99.62 | - | - | - | - | 0 |
Financing Cash Flow | -1,126 | -1,026 | -790.2 | -568.61 | -497.45 | -287.43 |
Foreign Exchange Rate Adjustments | -49.36 | -6.07 | 12.67 | 8.69 | -9.13 | -14 |
Net Cash Flow | 832.35 | 76.5 | -126.25 | 567.66 | -137.9 | -452.78 |
Free Cash Flow | 1,520 | 1,211 | 917.24 | 1,096 | 559.17 | 430.28 |
Free Cash Flow Growth | 101.73% | 32.02% | -16.32% | 96.02% | 29.96% | -40.39% |
Free Cash Flow Margin | 33.18% | 26.46% | 20.22% | 27.89% | 18.35% | 16.90% |
Free Cash Flow Per Share | 1.93 | 1.54 | 1.17 | 1.40 | 0.71 | 0.55 |
Cash Income Tax Paid | 482.66 | 431.05 | 296.84 | 192.82 | 80.06 | 200.54 |
Levered Free Cash Flow | -28.85 | 814.48 | 551.87 | 705.91 | 198.4 | 213.19 |
Unlevered Free Cash Flow | -28.54 | 814.81 | 552.14 | 706.18 | 198.57 | 213.29 |
Change in Working Capital | -321.97 | -321.97 | -690.86 | -324.83 | -385.54 | -260.16 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.